Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice

Psychopharmacology

Volumn 210, Issue 4, 2010, Pages 533-545

  Magnani, Paolo ^a   Conforti, Anita ^a   Zanolin, Elisabetta ^a   Marzotto, Marta ^a   Bellavite, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Animal models of anxiety; Complementary medicine; Gelsemine; Gelsemium sempervirens; Light dark test; Nanopharmacology; Open field test; Ultra low doses

Indexed keywords

BUSPIRONE; GELSEMIUM SEMPERVIRENS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG STRUCTURE; GELSEMIUM; GELSEMIUM SEMPERVIRENS; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BUSPIRONE; CHOICE BEHAVIOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; GELSEMIUM; HOMEOPATHY; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PLANT EXTRACTS; RANDOM ALLOCATION;

EID: 77955662297     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1855-2     Document Type: Article

References (90)

1. Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP (2003) WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr 8:53-61 (Pubitemid 38419781)
2. Arani R, Bono I, Del Giudice E, Preparata G (1995) QED coherence and the thermodynamics of water. Int J Mod Phys B9:1813-1841
3. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessivecompulsive and posttraumatic stress disorders. World J Biol Psychiatry 3:171-199
4. Barbancey J (1987) Pratique Homéopathique en psycho-pathologie, Tome II. Editions Similia, Paris
5. Bellavite P, Conforti A, Ortolani R (2006a) Immunology and homeopathy. 3. Experimental studies on animal models. Evid Based Complement Alternat Med 3:171-186
6. Bellavite P, Conforti A, Pontarollo F, Ortolani R (2006b) Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med 3:13-24
7. Bellavite P, Magnani P, Marzotto M, Conforti A (2009a) Assays of homeopathic remedies in rodent behavioural and psychopathological models. Homeopathy 98:208-227
8. Bellavite P, Magnani P, Zanolin E, Conforti A (2009b) Homeopathic doses of Gelsemium sempervirens improve the behavior of mice in response to novel environments. Evid. Based. Complement Alternat. Med. doi:10.1093/ecam/nep139
9. Belon P, Cumps J, Ennis M, Mannaioni PF, Roberfroid M, Sainte-Laudy J, Wiegant FA (2004) Histamine dilutions modulate basophil activation. Inflamm Res 53:181-188
10. Belougne-Malfatti E, Aguejouf O, Doutremepuich F, Belon P, Doutremepuich C (1998) Combination of two doses of acetyl salicylic acid: experimental study of arterial thrombosis. Thromb Res 90:215-221
11. Belzung C, Griebel G (2001) Measuring normal and pathological anxietylike behaviour in mice: a review. Behav Brain Res 125:141-149
12. Bilkei-Gorzo A, Gyertyan I, Levay G (1998) mCPP-induced anxiety in the light-dark box in rats-a new method for screening anxiolytic activity. Psychopharmacology (Berl) 136:291-298
13. Binsard AM (1979) Etude psycho-pharmacologique d'Ignatia et rapprochement avec un autre polychreste. Ann Homéop Fr 21:369-378
14. Binsard AM, Guillemain J, Platel A, Savini EC, Tetau M (1980) Etude psycho-pharmacologique de dilutions homéopathiques de Gelsemium et d'Ignatia. Ann Homéop Fr 22:35-50
15. Birzniece V, Backstrom T, Johansson IM, Lindblad C, Lundgren P, Lofgren M, Olsson T, Ragagnin G, Taube M, Turkmen S, Wahlstrom G, Wang MD, Wihlback AC, Zhu D (2006) Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev 51:212-239
16. Boericke W (1927) Materia medica with repertory, 9th edn. Boericke & Tafel Inc, Santa Rosa
17. Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463:55-65
18. Bourin M, Petit-Demouliere B, Dhonnchadha BN, Hascoet M (2007) Animal models of anxiety in mice. Fundam Clin Pharmacol 21:567-574
19. Bousta D, Soulimani R, Jarmouni I, Belon P, Falla J, Foment N, Younos C (2001) Neurotropic, immunological and gastric effects of low doses of Atropa belladonna L., Gelsemium sempervirens L. and Poumon histamine in stressed mice. J Ethnopharmacol 74:205-215
20. Brown V, Ennis M (2001) Flow-cytometric analysis of basophil activation: inhibition by histamine at conventional and homeopathic concentrations. Inflamm Res 50 (2):S47-S48
21. Carpenter JS, Neal JG (2005) Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology, and homeopathy. Am J Med 118 (Suppl 12B): 109-117
22. Chaplin MF (2007) The memory of water: an overview. Homeopathy 96:143-150
23. Chen SW, Min L, Li WJ, Kong WX, Li JF, Zhang YJ (2004) The effects of angelica essential oil in three murine tests of anxiety. Pharmacol Biochem Behav 79:377-382
24. Chirumbolo S, Brizzi M, Ortolani R, Vella A, Bellavite P (2009) Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res 58:755-764
25. Choleris E, Thomas AW, Kavaliers M, Prato FS (2001) A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25:235-260
26. Clement Y, Joubert C, Kopp C, Lepicard EM, Venault P, Misslin R, Cadot M, Chapouthier G (2007) Anxiety in mice: a principal component analysis study. Neural Plast 2007:35457
27. Cloos JM, Ferreira V (2009) Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 22:90-95
28. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl) 114:288-296
29. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777-785
30. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170
31. de Araujo FY, Silva MI, Moura BA, de Oliveira GV, Leal LK, Vasconcelos SM, Viana GS, de Moraes MO, de Sousa FC, Macedo DS (2009) Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice. J Pharm Pharmacol 61:1521-1527
32. Del Giudice E, Preparata G (1998) Coherence electrodynamics in water In: Schulte J, Endler C (eds) Fundamental research in ultrahigh dilution and homeopathy. Kluwer, Dordrecht, pp 89-100
33. Demangeat JL (2009) NMR water proton relaxation in unheated and heated ultrahigh aqueous dilutions of histamine: evidence for an air-dependent supramolecular organization of water. J Mol Liquids 144:32-39
34. Demangeat JL, Gries P, Poitevin B, Droesbeke JJ, Zahaf T, Maton F, Piérart C, Muller RN (2004) Low-field NMR water proton longitudinal relaxation in ultrahighly diluted aqueous solutions of silica-lactose prepared in glass material for pharmaceutical use. Appl Magn Reson 26:465-481
35. Demarque D, Jouanny J, Poitevin B, Saint-Jean Y (1995) Pharmacologie et matière médicale homéopathique, 2nd edn. Boiron, C. E. DH, Lyon, France
36. Eizayaga FX, Aguejouf O, Belon P, Doutremepuich C (2005) Platelet aggregation in portal hypertension and its modification by ultralow doses of aspirin. Pathophysiol Haemost Thromb 34:29-34
37. Elia V, Baiano S, Duro I, Napoli E, Niccoli M, Nonatelli L (2004) Permanent physico-chemical properties of extremely diluted aqueous solutions of homeopathic medicines. Homeopathy 93:144-150
38. Elia V, Napoli E, Germano R (2007) The 'Memory of Water': an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy 96:163-169
39. Fukushiro DF, Benetti LF, Josino FS, Oliveira GP, Fernandes MD, Saito LP, Uehara RA, Wuo-Silva R, Oliveira CS, Frussa-Filho R (2009) Environmental novelty and illumination modify ethanolinduced open-field behavioral effects in mice. Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2009.12.001
40. Greeson JM, Rosenzweig S, Halbert SC, Cantor IS, Keener MT, Brainard GC (2008) Integrative medicine research at an academic medical center: patient characteristics and health-related qualityof-life outcomes. J Altern Complement Med 14:763-767
41. Griebel G, Belzung C, Msslin R, Vogel E (1993) The free exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia reducing drugs. Behav Pharmacol 4:637-644
42. Grundmann O, Nakajima JI, Seo S, Butterweck V (2007) Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 110:406-411
43. Guermonprez M (2006) Homéopathie, Principles-Clinique-Techniques. CEDH, Paris
44. Guethlin C, Walach H, Naumann J, Bartsch HH, Rostock M (2009) Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study. Ann Oncol. doi:10.1093/annonc/mdp421
45. Guillemain J, Rousseau A, Dorfman P, Tetau M (1989) Recherche en psychopharmacologie. Cah Biother 103:53-66
46. Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N (2006) Anxiolytic activity of a novel potent serotonin 5-HT (2C) receptor antagonist FR260010: a comparison with diazepam and buspirone. Eur J Pharmacol 553:171-184
47. Hascoet M, Bourin M, Dhonnchadha BA (2001) The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 25:141-166
48. Irwin RE, Adler LS (2006) Correlations among traits associated with herbivore resistance and pollination: implications for pollination and nectar robbing in a distylous plant. Am J Bot 93:64-72
49. Khan A, Haleem DJ (2007) Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors. Acta Biol Hung 58:345-357
50. Lader M (2008) Effectiveness of benzodiazepines: do they work or not? Expert Rev Neurother 8:1189-1191
51. Lai CK, Chan YW (2009) Confirmation of gelsemium poisoning by targeted analysis of toxic gelsemium alkaloids in urine. J Anal Toxicol 33:56-61
52. Lamprea MR, Cardenas FP, Setem J, Morato S (2008) Thigmotactic responses in an open-field. Braz J Med Biol Res 41:135-140
53. Le Melledo JM, Baker G (2004) Role of progesterone and other neuroactive steroids in anxiety disorders. Expert Rev Neurother 4:851-860
54. Mamtani R, Cimino A (2002) A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatr Q 73:367-381
55. Marotta D, Marini A, Banaudha K, Maharaj SV, Jonas WB (2003) Nonlinear effects of glutamate and KCl on glutamate toxicity in cultured rat cerebellar neurons. Int J Neurosci 113:491-502
56. Mastrangelo D (2007) Hormesis, epitaxy, the structure of liquid water, and the science of homeopathy. Med Sci Monit 13: Sr1-SR8
57. Mathie RT, Robinson TW (2006) Outcomes from homeopathic prescribing in medical practice: a prospective, research-targeted, pilot study. Homeopathy 95:199-205
58. Merali Z, Levac C, Anisman H (2003) Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54:552-565
59. Mi XJ, Chen SW, Wang WJ, Wang R, Zhang YJ, Li WJ, Li YL (2005) Anxiolytic-like effect of paeonol in mice. Pharmacol Biochem Behav 81:683-687
60. Miller LG, Koff JM (1994) Interaction of central and peripheral benzodiazepine sites in benzodiazepine tolerance and discontinuation. Prog Neuropsychopharmacol Biol Psychiatry 18:847-857
61. Morgan AJ, Jorm AF (2009) Outcomes of self-help efforts in anxiety disorders. Expert Rev Pharmacoecon Outcomes Res 9:445-459
62. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX (2006) Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138:749-756
63. Patte-Mensah C, Kibaly C, Boudard D, Schaeffer V, Begle A, Saredi S, Meyer L, Mensah-Nyagan AG (2006) Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci 28:17-31
64. Peredery O, Persinger MA (2004) Herbal treatment following postseizure induction in rat by lithium pilocarpine: Scutellaria lateriflora (Skullcap), Gelsemium sempervirens (Gelsemium) and Datura stramonium (Jimson Weed) may prevent development of spontaneous seizures. Phytother Res 18:700-705
65. Pilkington K, Kirkwood G, Rampes H, Fisher P, Richardson J (2006a) Homeopathy for anxiety and anxiety disorders: a systematic review of the research. Homeopathy 95:151-162
66. Pilkington K, Rampes H, Richardson J (2006b) Complementary medicine for depression. Expert Rev Neurother 6:1741-1751
67. Pogorelov VM, Lanthorn TH, Savelieva KV (2007) Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice. J Neurosci Methods 162:222-228
68. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33
69. Ramos A, Pereira E, Martins GC, Wehrmeister TD, Izidio GS (2008) Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 193:277-288
70. Rao ML, Roy R, Bell IR, Hoover R (2007) The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy 96:175-182
71. Ruiz-Vega G, Estevez-Delgado G (2008) Non-linearity modeling of ultra-dilutions: the histamine disturbances case. In: Bonamin LV (ed) Signals and images. Contributions and contradictions about high dilution research. Dordrecht: Springer Science, pp 67-82
72. Sainte-Laud J, Belon P (2009) Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions. Homeopathy 98:186-197
73. Schosser A, Kasper S (2009) The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol 24:277-288
74. Schun Y, Cordell GA (1987) Cytotoxic steroids of Gelsemium sempervirens. J Nat Prod 50:195-198
75. Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K, Watanabe H (1995) The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26:205-210
76. Simon P, Dupuis R, Costentin J (1994) Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61:59-64
77. Smith CW (2004) Quanta and coherence effects in water and living systems. J Altern Complement Med 10:69-78
78. Sukul NC, Bala SK, Bhattacharyya B (1986) Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology (Berl) 89:338-339
79. Thompson LJ, Frazier K, Stiver S, Styer E (2002) Multiple animal intoxications associated with Carolina jessamine (Gelsemium sempervirens) ingestions. Vet Hum Toxicol 44:272-273
80. Thompson EA, Mathie RT, Baitson ES, Barron SJ, Berkovitz SR, Brands M, Fisher P, Kirby TM, Leckridge RW, Mercer SW, Nielsen HJ, Ratsey DH, Reilly D, Roniger H, Whitmarsh TE (2008) Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy 97:114-121
81. Valnet J (1992) Phytothérapie. Maloine, Paris
82. Vasconcelos SM, Lima SR, Soares PM, Assreuy AM, de Sousa FC, Lobato RF, Vasconcelos GS, Santi-Gadelha T, Bezerra EH, Cavada BS, Patrocinio MC (2009) Central action of Araucaria angustifolia seed lectin in mice. Epilepsy Behav 15:291-293
83. Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C (2008) Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 153:154-161
84. Venard C, Boujedaini N, Mensah-Nyagan AG, Patte-Mensah C (2009) Comparative analysis of gelsemine and Gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid Based Complement Alternat Med. doi:10.1093/ecam/nep083
85. Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83 (3):482-504
86. Witt CM, Bluth M, Albrecht H, Weisshuhn TE, Baumgartner S, Willich SN (2007) The in vitro evidence for an effect of high homeopathic potencies-a systematic review of the literature. Complement Ther Med 15:128-138
87. Yamauchi M, Dostal J, Kimura H, Strohl KP (2008) Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains. J Appl Physiol 105:518-526
88. Young R, Johnson DN (1991a) Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test. Pharmacol Biochem Behav 40:733-737
89. Young R, Johnson DN (1991b) A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40:739-743
90. Young R, Batkai S, Dukat M, Glennon RA (2006) TDIQ (5, 6, 7, 8-tetrahydro-1, 3-dioxolo[4, 5-g]isoquinoline) exhibits anxiolyticlike activity in a marble-burying assay in mice. Pharmacol Biochem Behav 84:62-73